This article is for educational purposes only and does not constitute medical advice. Persistent or severe hyperpigmentation should be assessed by a qualified dermatologist. Individual results vary.
If you are searching for why dark spots take so long to fade, why PIH is worse on Indian skin, the difference between epidermal and dermal pigmentation, or which ingredients are documented to help — this guide covers the complete mechanism, with an evidence-based routine.
Post-inflammatory hyperpigmentation (PIH) is excess melanin deposition following an inflammatory event. It is not a cosmetic stain — it is the skin's active melanocyte response to inflammatory mediators produced during injury or irritation. PIH is among the most prevalent skin concerns in Indian and South Asian populations, driven by higher baseline melanocyte reactivity in Fitzpatrick III–VI skin. Understanding its mechanism is the prerequisite for understanding why certain ingredients work and others do not.
- PIH is an active biological response — not a passive stain. Inflammation triggers melanocytes; melanocytes overproduce melanin; melanin deposits in the epidermis (and sometimes dermis), creating visible pigmentation.
- Epidermal PIH (brown marks) responds to topical brightening actives. Dermal PIH (grey-blue marks) is significantly more resistant — early intervention is the most important factor.
- Fitzpatrick III–VI skin produces more PIH from the same inflammatory stimulus due to higher melanocyte reactivity — this is biological, not a deficiency.
- SPF is the single most important PIH management step — UV continuously restimulates tyrosinase, opposing the effect of every brightening active used without sun protection.
- No single ingredient addresses the full melanogenesis cascade. Multi-active protocols are consistently more effective than single-active approaches in the reviewed literature.
- Resolution takes time. Epidermal PIH fades over months, not days — 8–24 weeks is the documented timeframe in peer-reviewed brightening trials.
- What is PIH — and why it is not a stain
- How PIH forms: the inflammation-melanin mechanism
- Epidermal vs dermal PIH — why the distinction matters
- Why PIH is more pronounced on Indian and deeper skin tones
- The most common PIH triggers
- The PIH resolution timeline
- Ingredients documented for PIH-associated pigmentation
- What makes PIH worse
- SPF — why it outweighs every active ingredient
- The complete PIH skincare protocol
- Common PIH myths
- Frequently asked questions
Post-inflammatory hyperpigmentation is the most common pigmentation concern seen in dermatology practices serving South Asian, African, and Middle Eastern populations — yet also the most misunderstood. Framing PIH as a "stain" creates the expectation that it responds quickly to topical treatment. It does not — and the reason is mechanistic, not a failure of the ingredient or the routine.
What Is PIH — and Why It Is Not a Stain
PIH is the skin's melanocyte response to inflammation. When skin experiences an inflammatory event — acne, eczema, contact with an irritating ingredient, or physical trauma — the inflammatory cascade produces prostaglandins, leukotrienes, interleukins, and reactive oxygen species. These stimulate melanocytes to produce excess melanin, far beyond what normal pigmentation requires.
The excess melanin is transferred to keratinocytes and deposited in the skin. As keratinocytes migrate upward over 28–40 days, they carry the excess melanin — creating the visible dark mark. The original inflammatory event may have resolved, but the melanin it triggered continues to be produced for weeks afterwards.
This is what makes PIH different from a stain. A stain is passive. PIH is active: melanocytes remain in elevated activity after inflammation, continuously producing excess melanin until the biological stop signal overrides the inflammatory stimulus. Without active intervention — particularly consistent SPF — UV continuously re-triggers the same pathway, preventing resolution.
"PIH is not a stain left by inflammation. It is an active wound response that continues producing melanin after the original injury has healed."
Boldpurity Science TeamHow PIH Forms: The Inflammation-Melanin Mechanism
Step 1 — Inflammatory mediator release. The initial skin insult triggers keratinocytes to release arachidonic acid metabolites, converted into prostaglandins (PGE2, PGD2), leukotrienes, and cytokines including IL-1 and TNF-α.
Step 2 — Melanocyte activation. Inflammatory mediators directly stimulate melanocytes to upregulate tyrosinase expression. Prostaglandins activate MC1R signalling. UV exposure amplifies this further through α-MSH pathway activation. The combined effect is a disproportionate increase in melanin production relative to normal skin function.
Step 3 — Melanin deposition. Excess melanin is packaged into melanosomes and transferred to surrounding keratinocytes. As keratinocytes migrate upward over 28–40 days, they carry the deposits — creating the visible mark.
In severe inflammation, an additional pathway activates: melanin breaches the dermo-epidermal junction into the dermis via macrophages — creating the deeper, more persistent dermal PIH form.
Inflammatory event → prostaglandins + leukotrienes → melanocyte MC1R / α-MSH signalling → tyrosinase upregulation → excess melanin synthesis → melanosome transfer to keratinocytes → epidermal melanin deposition → visible PIH as cells migrate to surface.
Severe inflammation: melanin breaches dermo-epidermal junction → macrophage uptake in dermis → dermal PIH — grey-blue, significantly more treatment-resistant.
UV exposure at any point re-activates α-MSH signalling and tyrosinase — restarting melanin overproduction. SPF is therefore the prerequisite — without it, the brightening cascade cannot function effectively against continuous UV stimulus.
Epidermal vs Dermal PIH — Why the Distinction Matters
| Property | Epidermal PIH | Dermal PIH |
|---|---|---|
| Melanin location | Upper epidermal layers | Dermis — via macrophages through the dermo-epidermal junction |
| Appearance | Brown · Tan · Dark brown | Grey · Blue-grey · Ash-coloured |
| Wood's lamp | Contrast accentuated under UV light | Contrast not accentuated |
| Topical treatment response | Responds to tyrosinase inhibitors, cell turnover actives, SPF | Significantly more resistant — laser or professional intervention may be indicated |
| Typical resolution | 3–24 months without treatment; 2–6 months with consistent actives + SPF | Years without professional intervention; may persist long-term |
| Primary cause | Moderate inflammatory events | Severe or prolonged inflammation, deep trauma, aggressive procedures |
Most post-acne marks in Indian skin are epidermal or mixed. Brown marks present for less than 12 months that remain darker than surrounding skin are predominantly epidermal — responsive to consistent topical protocols. Grey or ashen marks following cystic acne, deep trauma, or aggressive chemical peels may have significant dermal involvement and warrant dermatological assessment.
Why PIH Is More Pronounced on Indian and Deeper Skin Tones
Higher melanocyte reactivity — not higher melanocyte count. Fitzpatrick III–VI skin does not contain more melanocytes per unit area. What differs is melanocyte activity: in deeper skin tones, melanocytes are larger, more dendritic, and produce larger melanosomes containing more melanin per cell. The same inflammatory stimulus triggers proportionally greater melanin output.
Greater inflammatory amplification. Dermatology research documents that Fitzpatrick III–VI skin has greater upregulation of melanocyte-stimulating pathways in response to inflammatory mediators — producing a larger melanocyte response at equivalent inflammatory intensity.
Longer natural resolution. Higher melanin density per keratinocyte means more turnover cycles are required to clear the excess — even when the inflammatory trigger has resolved and no new melanin is being produced.
The disproportionate PIH burden on Indian skin is not a weakness — it is a biological characteristic of higher-reactivity melanocytes. The appropriate response is not stronger ingredients; it is smarter ingredient selection — actives that modulate melanocyte signalling without triggering new inflammation, combined with rigorous sun protection that removes the primary continuous trigger. Aggressive treatments that cause irritation create a PIH-from-treatment cycle that worsens the condition they are intended to address.
The Most Common PIH Triggers
| Trigger | Mechanism | PIH Risk |
|---|---|---|
| Acne lesions | Inflammatory cascade from immune response; squeezing extends and deepens inflammation significantly | Very high — most common PIH source |
| Eczema / atopic dermatitis flares | Chronic inflammatory cytokines (IL-4, IL-13) continuously stimulate melanocytes in affected areas | Very high — repeated flares create progressive PIH accumulation |
| Waxing / threading | Physical trauma to follicle + perifollicular inflammation; microtrauma along follicle lines | High — upper lip and eyebrow areas particularly |
| Irritating skincare actives | Excessive concentrations of AHAs, retinoids, vitamin C trigger contact dermatitis → PIH | Very high — most common skincare-induced PIH route |
| Laser / chemical peels | Controlled tissue injury; post-procedure PIH is a documented risk — higher in Fitzpatrick IV–VI without appropriate protocols | High — requires dermatologist assessment before ablative procedures |
| UV on inflamed skin | UV amplifies melanocyte response to existing inflammation; simultaneous inflammatory + UV stimulus creates disproportionate PIH | Very high — Indian sun + any skin inflammation is the highest-risk combination |
The PIH Resolution Timeline — Why It Takes So Long
The keratinocyte cycle governs visible fading. Brightening actives modulate ongoing melanin synthesis — they do not remove melanin already present in keratinocytes. Visible fading requires those cells to naturally reach the surface and shed, replaced by less-pigmented cells. This takes 28–40 days per cycle in younger skin, 40–60 days over 40, and longer with compromised barrier function.
UV stimulus resets the clock. Every day UV reaches unprotected skin, tyrosinase is re-stimulated. New melanin production offsets the reduction achieved by brightening actives. SPF is therefore the first priority, not the last — without it, actives work against a continuous opposing signal.
Epidermal PIH with consistent actives + daily SPF: Measurable improvement at 4–8 weeks; visible improvement at 8–16 weeks; significant fading at 16–24 weeks.
Without SPF: Minimal improvement regardless of active ingredient use — UV continuously restimulates the target pathway.
Dermal PIH: Seek dermatological assessment for realistic prognosis and appropriate intervention options.
Ingredients Documented for PIH-Associated Pigmentation Support
| Ingredient | Mechanism | Where It Acts | Evidence |
|---|---|---|---|
| Tranexamic Acid | Blocks plasminogen-keratinocyte signalling that activates melanocytes; prostaglandin modulation | Upstream — prevents activation | Strong — multiple RCTs in PIH populations |
| Undecylenoyl Phenylalanine | Modulates α-MSH receptor signalling — upstream hormonal trigger for melanocyte activation | Upstream — α-MSH receptor | Moderate — in vitro and formulation studies |
| Alpha-Arbutin | Reversible competitive tyrosinase inhibition | At tyrosinase — enzyme level | Strong — in vitro, ex vivo, clinical; EU SCCS reviewed |
| Niacinamide | Associated with inhibiting melanosome transfer from melanocyte to keratinocyte | Downstream — after melanin is produced | Strong — multiple clinical trials |
| Vitamin C (L-Ascorbic Acid) | Reduces dopaquinone → DOPA; chelates copper at tyrosinase; antioxidant reduces ROS-driven melanocyte stimulation | Mid-pathway + antioxidant | Strong — extensively documented |
| Azelaic Acid | Tyrosinase inhibition + anti-inflammatory — addresses enzyme and inflammatory trigger simultaneously | At tyrosinase + upstream inflammation | Strong — particularly for acne-associated PIH |
| AHAs (Lactic, Glycolic) | Accelerate keratinocyte shedding — bringing melanin-containing cells to surface faster | Downstream — accelerates natural resolution | Moderate — complementary; use carefully to avoid irritation-triggered new PIH |
| Retinoids | Accelerate cell turnover; associated with downregulating tyrosinase gene expression; reduce melanosome transfer | Multiple cascade points + cell turnover | Strong — but irritation risk requires careful management |
Tranexamic Acid + Alpha-Arbutin + Niacinamide + Vitamin C + Daily SPF represents the broadest documented cascade coverage for PIH-associated pigmentation. TXA blocks upstream activation; Alpha-Arbutin inhibits tyrosinase; Niacinamide prevents melanosome transfer; Vitamin C reduces mid-pathway conversion; SPF prevents UV from restimulating the entire cascade daily.
This is a mechanistically designed protocol — not a marketing stack. No single product will contain all actives at meaningful concentrations. A multi-product protocol or precision-formulated multi-active serum is required for comprehensive coverage.
What Makes PIH Worse
- Squeezing or picking acne lesions — the single most damaging behaviour. Squeezing extends the inflammatory cascade and deepens tissue trauma, converting epidermal PIH into mixed or dermal PIH. The visible mark from a picked spot is consistently darker and more persistent than from an unpicked lesion of equivalent severity.
- Strong exfoliants at excessive concentrations — high-percentage glycolic acid, salicylic acid, or retinoids in unacclimatised skin causes contact irritation, triggering new inflammatory PIH. The irony: actives intended to clear PIH create new PIH from the irritation response.
- Physical scrubs on active pigmentation — creates microtrauma and inflammatory signals that further stimulate melanocytes.
- Skipping SPF — UV re-activates tyrosinase in sensitised melanocytes daily, continuously worsening and resetting PIH regardless of actives applied.
- Waxing or threading over active marks — physical trauma to skin displaying PIH can extend melanocyte activity and deepen the mark.
SPF — The Most Important Single Step
UV radiation directly upregulates tyrosinase. Every time UV reaches unprotected skin, α-MSH signalling activates and tyrosinase expression increases in melanocytes. For skin already in a state of post-inflammatory melanocyte hyperactivity, this UV stimulus adds to an elevated baseline — producing more melanin, deepening existing marks, and extending the resolution timeline.
Without sun protection, brightening actives cannot outpace UV stimulation. If tyrosinase inhibitors reduce melanin output by X, and daily UV re-stimulation increases it by an amount approaching X, the net brightening effect approaches zero. Published brightening trials consistently show improved outcomes in SPF-compliant groups — in several studies, the sun protection effect size exceeds that of the active ingredient alone.
Guidance for Indian skin: Broad-spectrum SPF 30–50+ daily, every day — including overcast days. For Fitzpatrick IV–VI skin, chemical SPF formulations with PA++++ are preferred where white cast from physical formulations reduces compliance. A cosmetically compatible SPF used consistently outperforms a perfect formulation used intermittently.
The Complete PIH Skincare Protocol
Harsh cleansers strip ceramides and disrupt the acid mantle, amplifying inflammatory responses. A gentle amino acid-based or low-surfactant cleanser is the foundation. Avoid physical scrub cleansers entirely on skin with active PIH.
Apply to clean, slightly damp skin before heavier emollients. Look for a formula containing actives addressing at least two distinct cascade steps — ideally an upstream blocker (Tranexamic Acid or Undecylenoyl Phenylalanine) alongside a tyrosinase inhibitor (Alpha-Arbutin). For maximum coverage, add Niacinamide in the same or subsequent serum step.
A ceramide moisturiser seals the active layers and maintains barrier integrity. A compromised barrier means active ingredients diffuse inefficiently and inflammatory triggers penetrate more easily — both worsening PIH.
Applied as the final morning step after all actives and moisturiser. PA++++ rating indicates the highest UVA protection tier in the PA system used across India and Asia. Reapply every 2 hours during extended outdoor exposure. Without this step, all preceding steps are significantly less effective.
Cell turnover actives accelerate removal of melanin-containing keratinocytes. Introduce at lowest available concentration 2–3 times per week, building tolerance over 4–6 weeks before increasing frequency. Never use at concentrations that cause visible peeling, redness, or burning — irritation triggers new PIH that can exceed the clearing benefit.
Common PIH Myths
PIH can fade on its own — but on Fitzpatrick IV–VI skin without intervention, "eventually" may mean 24 months or longer. And it will not fade at all if UV exposure is continuously restimulating tyrosinase. PIH is an active biological response involving ongoing melanin production — which requires active management, not passive waiting.
Fact: PIH involves ongoing melanocyte activity. Without SPF, UV continuously restimulates melanin production. Active intervention with documented brightening actives shortens resolution from years to months in the published literature.
High-percentage glycolic acid, salicylic acid, or physical scrubs applied to PIH-prone skin frequently cause contact irritation — triggering new inflammatory PIH in the areas being treated. The result is a cycle of treatment-induced inflammation and new pigmentation that worsens the condition over months. Gentle cell turnover acceleration is the evidence-based approach — not aggressive exfoliation.
Fact: Gentle AHA use (5–10% lactic acid; 5–8% glycolic) with slow introduction is documented. Any exfoliant causing visible peeling, sustained redness, or burning is triggering new inflammation — and new PIH.
Lemon juice applied topically is a photosensitiser — its furanocoumarins react with UV to cause phytophotodermatitis, producing new and often severe hyperpigmentation that is significantly more difficult to address than the original PIH. Turmeric has documented anti-inflammatory activity in laboratory models, but topically applied turmeric paste has not demonstrated meaningful clinical brightening efficacy equivalent to formulated brightening actives and commonly causes temporary skin staining.
Fact: Lemon juice is phototoxic and can cause severe PIH. Turmeric lacks clinical brightening evidence equivalent to documented tyrosinase inhibitors. Formulated actives at evidence-supported concentrations represent the science-based approach.
Frequently Asked Questions
- Davis, E.C., & Callender, V.D. (2010). Postinflammatory hyperpigmentation: a review of the epidemiology, clinical features, and treatment options in skin of color. Journal of Clinical and Aesthetic Dermatology, 3(7), 20–31.
- Kaufman, B.P., et al. (2018). Postinflammatory hyperpigmentation: epidemiology, clinical presentation, pathogenesis and treatment. American Journal of Clinical Dermatology, 19(4), 489–503.
- Silpa-archa, N., et al. (2017). Postinflammatory hyperpigmentation: a comprehensive overview. Journal of the European Academy of Dermatology and Venereology, 31(6), 960–976.
- Nouveau, S., et al. (2006). Skin hyperpigmentation in Indian women: a stereological and histological characterization. Skin Pharmacology and Physiology, 19(3), 148–155.
- Kang, H.Y., & Ortonne, J.P. (2010). What should be considered in treatment of melasma. Annals of Dermatology, 22(4), 373–378.
- Desai, S.R. (2014). Hyperpigmentation therapy: a review. Journal of Clinical and Aesthetic Dermatology, 7(8), 13–17.
- Ortonne, J.P., & Bissett, D.L. (2008). Latest insights into skin hyperpigmentation. Journal of Investigative Dermatology Symposium Proceedings, 13(1), 10–14.
- Boo, Y.C. (2021). Arbutin as a skin depigmenting agent with antimelanogenic and antioxidant properties. Antioxidants, 10(7), 1129.
© 2026 Boldpurity · For educational purposes only · Not to be reproduced without permission.
